Supplementary tables: Costs and outcomes of mobile cardiac outpatient telemetry monitoring post-transcatheter aortic valve replacement

These are peer-reviewed supplementary materials for the article 'Costs and outcomes of mobile cardiac outpatient telemetry monitoring post-transcatheter aortic valve replacement' published in the Journal of Comparative Effectiveness Research.Supplementary Table 1: CPT and ICD-10 CodesSupplementary Table 2: Propensity score adjusted revenue center costs for patients with MCOT monitoring versus non-MCOT monitoring post-TAVR procedureAim: To estimate the costs and outcomes of transcatheter aortic valve replacement (TAVR) recipients based on the use of mobile cardiac outpatient telemetry (MCOT) monitoring. Materials & methods: A retrospective database study was conducted to estimate costs, contribution margins (CMs), pacemaker insertions and other outcomes for patients undergoing TAVR procedures with MCOT monitoring postprocedure versus non-MCOT monitoring. Results: A total of 4164 patients were identified (283 MCOT monitoring and 3881 non-MCOT monitoring). The rate of pacemaker insertion following hospital discharge was higher in the MCOT cohort (6.6 MCOT vs 2.1% non-MCOT; p = 0.007). MCOT use was associated with lower costs and improved CMs of the index TAVR admission (costs: US$40,569 MCOT vs $43,289 non-MCOT; p = 0.003; CMs: US$7087 MCOT vs $5177 non-MCOT; p = 0.047) with no difference through the subsequent 60-day period following discharge. Conclusion: MCOT for ambulatory cardiac monitoring post-TAVR discharge is associated with higher rates of pacemaker insertion, at no overall greater costs.

本数据集为发表于《比较疗效研究杂志》的论文《经导管主动脉瓣置换术后移动心电门诊遥测监测的成本与结果》的同行评审补充材料。补充表1：CPT及ICD-10编码；补充表2：TAVR术后MCOT监测与非MCOT监测患者的倾向得分调整后的收入中心成本。研究目的：基于移动心电门诊遥测（MCOT）监测的使用情况，估算经导管主动脉瓣置换术（TAVR）受术者的成本与结果。研究方法：进行了一项回顾性数据库研究，以估算TAVR术后接受MCOT监测与未接受MCOT监测的患者在成本、贡献边际（CMs）、起搏器植入及其他结果方面的差异。研究结果：共确定了4164名患者（283名接受MCOT监测，3881名未接受MCOT监测）。出院后植入起搏器的比例在MCOT组中较高（MCOT组为6.6%，非MCOT组为2.1%；p = 0.007）。MCOT的使用与TAVR入院时的成本降低和贡献边际改善相关（成本：MCOT组为40,569美元，非MCOT组为43,289美元；p = 0.003；贡献边际：MCOT组为7087美元，非MCOT组为5177美元；p = 0.047），且在出院后的随后的60天期间内无显著差异。研究结论：TAVR术后出院后的门诊心电监测采用MCOT与起搏器植入率提高相关，但总体成本并未增加。